Evaluation of the safety and tolerability of spironolactone in patients with heart failure and chronic kidney disease

Amanda R. Buckallew, Katie B. Tellor, Rachel Watson, William Miller, Gina Mbachu, Cameron Whitlock, Jay R. Seltzer, Anastasia L. Armbruster

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)955-960
Number of pages6
JournalEuropean Journal of Clinical Pharmacology
Volume77
Issue number7
DOIs
StatePublished - Jul 2021

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)

Keywords

  • Aldosterone antagonist
  • Chronic kidney disease
  • Heart failure
  • Mineralocorticoid receptor antagonist
  • Renal impairment

Cite this